LEMONADE INC (LMND) Stock Analyst Ratings
NYSE:LMND • US52567D1072
53.26 USD
+1.52 (+2.94%)
At close: Mar 2, 2026
51.08 USD
-2.18 (-4.09%)
Pre-Market: 3/3/2026, 6:58:32 AM
ChartMill assigns a Buy % Consensus number of 69% to LMND. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 66.41. This target is 24.7% above the current price.
- LMND was analyzed by 18 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about LMND.
- In the last month the buy percentage rose by 15 points. So the trust of analysts is improving.
- LMND was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-24 | Keefe, Bruyette & Woods | Maintains | Underperform -> Underperform |
| 2026-01-14 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-01-06 | Truist Securities | Initiate | Buy |
| 2025-11-25 | Keefe, Bruyette & Woods | Maintains | Underperform -> Underperform |
| 2025-11-24 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-17 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-11-10 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-10-10 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-10-07 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-09-17 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-18 | BMO Capital | Maintains | Underperform -> Underperform |
| 2025-07-14 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-07-02 | BMO Capital | Maintains | Underperform -> Underperform |
| 2025-07-01 | Keefe, Bruyette & Woods | Reiterate | Underperform -> Underperform |
| 2025-04-22 | Keefe, Bruyette & Woods | Maintains | Underperform -> Underperform |
| 2025-04-08 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2025-02-26 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-26 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-22 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-11-21 | BMO Capital | Maintains | Underperform -> Underperform |
| 2024-11-21 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-20 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2024-11-15 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-11-07 | Keefe, Bruyette & Woods | Downgrade | Market Perform -> Underperform |
| 2024-11-01 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-10-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-10-09 | Jefferies | Maintains | Underperform -> Underperform |
| 2024-05-07 | Jefferies | Maintains | Underperform -> Underperform |
| 2024-05-02 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-04-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
LEMONADE INC / LMND FAQ
What do analysts expect the price target to be for LEMONADE INC (LMND)?
18 analysts have analysed LMND and the average price target is 66.41 USD. This implies a price increase of 24.7% is expected in the next year compared to the current price of 53.26.
What is the consensus rating for LEMONADE INC (LMND) stock?
The consensus rating for LEMONADE INC (LMND) is 68.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for LMND stock?
The number of analysts covering LEMONADE INC (LMND) is 18.